UNRESECTABLE THYROID GLAND CARCINOMA
Clinical trials for UNRESECTABLE THYROID GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE THYROID GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for rare, aggressive thyroid cancer
Disease control OngoingThis study tests whether combining lenvatinib (a drug that blocks cancer cell growth) with pembrolizumab (an immunotherapy that helps the immune system attack cancer) can help people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. The tria…
Matched conditions: UNRESECTABLE THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New drug combo targets Hard-to-Treat thyroid cancer
Disease control OngoingThis early-phase study tested a combination of two targeted drugs, dabrafenib and lapatinib, in 23 people with advanced thyroid cancer that could not be removed by surgery and had stopped responding to standard treatments. The goal was to find the safest dose of lapatinib when gi…
Matched conditions: UNRESECTABLE THYROID GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Promising combo therapy targets deadly thyroid cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help people with aggressive thyroid cancers (anaplastic or poorly differentiated) live longer. About 50 adults with advanced or inoperable cancer will receive different drug combinati…
Matched conditions: UNRESECTABLE THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC